Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Apheresis|May 6, 2020
Double-blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate-to-severe relapses of multiple sclerosisBruno Brochet, Mathilde Deloire, Christine Germain, et al.
Neurology and Therapy|February 11, 2022
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE StudyCaroline Papeix, Giovanni Castelnovo, Emmanuelle Leray, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2016
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled studyAyman Tourbah, Christine Lebrun-Frenay, Gilles Edan, et al.
The New England Journal of Medicine|June 22, 2007
Natural history of multiple sclerosis with childhood onsetChristel Renoux, Sandra Vukusic, Yann Mikaeloff, et al.
Trials|July 1, 2020
The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trialKatline Metzger-Peter, Laurent Daniel Kremer, Gilles Edan, et al.
Plos One|January 4, 2017
Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple SclerosisBruno Brochet, Mathilde S A Deloire, Paul Perez, et al.
Plos One|July 7, 2015
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational StudyEmmanuelle Leray, Sandra Vukusic, Marc Debouverie, et al.
CNS Drugs|May 30, 2018
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled StudyAyman Tourbah, Olivier Gout, Alain Vighetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2024
Association between education level and disability progression in patients with multiple sclerosis in FranceMathilde Lefort, Olivier Dejardin, Eric Berger, et al.
Archives of Neurology|October 10, 2007
Acute fulminant demyelinating disease: a descriptive study of 60 patientsJérôme de Seze, Marc Debouverie, Hélène Zephir, et al.
Pageof 8